Clinical utility of reverse phase protein array for molecular classification of breast cancer
Reverse Phase Protein Array (RPPA) represents a sensitive and high-throughput technique allowing simultaneous quantitation of protein expression levels in biological samples. This study aimed to confirm the ability of RPPA to classify archival formalin-fixed paraffin-embedded (FFPE) breast cancer ti...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2016
|
| Online Access: | https://eprints.nottingham.ac.uk/44244/ |
| _version_ | 1848796870347849728 |
|---|---|
| author | Negm, Ola H. Muftah, Abir A. Aleskandarany, Mohammed A. Hamed, Mohamed R. Ahmad, Dena A.J. Nolan, Christopher C. Diez-Rodriguez, Maria Tighe, Patrick J. Ellis, Ian O. Rakha, Emad A. Green, Andrew R. |
| author_facet | Negm, Ola H. Muftah, Abir A. Aleskandarany, Mohammed A. Hamed, Mohamed R. Ahmad, Dena A.J. Nolan, Christopher C. Diez-Rodriguez, Maria Tighe, Patrick J. Ellis, Ian O. Rakha, Emad A. Green, Andrew R. |
| author_sort | Negm, Ola H. |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | Reverse Phase Protein Array (RPPA) represents a sensitive and high-throughput technique allowing simultaneous quantitation of protein expression levels in biological samples. This study aimed to confirm the ability of RPPA to classify archival formalin-fixed paraffin-embedded (FFPE) breast cancer tissues into molecular classes used in the Nottingham prognostic index plus (NPI+) determined by immunohistochemistry (IHC). Proteins were extracted from FFPE breast cancer tissues using three extraction protocols: the Q-proteome FFPE Tissue Kit (Qiagen, Hilden, Germany) and two in-house methods using Laemmli buffer with either incubation for 20 min or 2 h at 105 °C. Two preparation methods, full-face sections and macrodissection, were used to assess the yield and quality of protein extracts. Ten biomarkers used for the NPI+ (ER, PgR, HER2, Cytokeratins 5/6 and 7/8, EGFR, HER3, HER4, p53 and Mucin 1) were quantified using RPPA and compared to results determined by IHC. The Q-proteome FFPE Tissue Kit produced significantly higher protein concentration and signal intensities. The intra- and inter-array reproducibility assessment indicated that RPPA using FFPE lysates was a highly reproducible and robust technique. Expression of the biomarkers individually and in combination using RPPA was highly consistent with IHC results. Macrodissection of the invasive tumour component gave more reliable results with the majority of biomarkers determined by IHC, (80 % concordance) compared with full-face sections (60 % concordance). Our results provide evidence for the technical feasibility of RPPA for high-throughput protein expression profiling of FFPE breast cancer tissues. The sensitivity of the technique is related to the quality of extracted protein and purity of tumour tissue. RPPA could provide a quantitative technique alternative to IHC for the biomarkers used in the NPI+. |
| first_indexed | 2025-11-14T19:54:51Z |
| format | Article |
| id | nottingham-44244 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T19:54:51Z |
| publishDate | 2016 |
| publisher | Springer |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-442442018-12-04T16:39:53Z https://eprints.nottingham.ac.uk/44244/ Clinical utility of reverse phase protein array for molecular classification of breast cancer Negm, Ola H. Muftah, Abir A. Aleskandarany, Mohammed A. Hamed, Mohamed R. Ahmad, Dena A.J. Nolan, Christopher C. Diez-Rodriguez, Maria Tighe, Patrick J. Ellis, Ian O. Rakha, Emad A. Green, Andrew R. Reverse Phase Protein Array (RPPA) represents a sensitive and high-throughput technique allowing simultaneous quantitation of protein expression levels in biological samples. This study aimed to confirm the ability of RPPA to classify archival formalin-fixed paraffin-embedded (FFPE) breast cancer tissues into molecular classes used in the Nottingham prognostic index plus (NPI+) determined by immunohistochemistry (IHC). Proteins were extracted from FFPE breast cancer tissues using three extraction protocols: the Q-proteome FFPE Tissue Kit (Qiagen, Hilden, Germany) and two in-house methods using Laemmli buffer with either incubation for 20 min or 2 h at 105 °C. Two preparation methods, full-face sections and macrodissection, were used to assess the yield and quality of protein extracts. Ten biomarkers used for the NPI+ (ER, PgR, HER2, Cytokeratins 5/6 and 7/8, EGFR, HER3, HER4, p53 and Mucin 1) were quantified using RPPA and compared to results determined by IHC. The Q-proteome FFPE Tissue Kit produced significantly higher protein concentration and signal intensities. The intra- and inter-array reproducibility assessment indicated that RPPA using FFPE lysates was a highly reproducible and robust technique. Expression of the biomarkers individually and in combination using RPPA was highly consistent with IHC results. Macrodissection of the invasive tumour component gave more reliable results with the majority of biomarkers determined by IHC, (80 % concordance) compared with full-face sections (60 % concordance). Our results provide evidence for the technical feasibility of RPPA for high-throughput protein expression profiling of FFPE breast cancer tissues. The sensitivity of the technique is related to the quality of extracted protein and purity of tumour tissue. RPPA could provide a quantitative technique alternative to IHC for the biomarkers used in the NPI+. Springer 2016-01-01 Article PeerReviewed application/pdf en https://eprints.nottingham.ac.uk/44244/1/26661092 Negm, Ola H., Muftah, Abir A., Aleskandarany, Mohammed A., Hamed, Mohamed R., Ahmad, Dena A.J., Nolan, Christopher C., Diez-Rodriguez, Maria, Tighe, Patrick J., Ellis, Ian O., Rakha, Emad A. and Green, Andrew R. (2016) Clinical utility of reverse phase protein array for molecular classification of breast cancer. Breast Cancer Research and Treatment, 155 (1). pp. 25-35. ISSN 1573-7217 https://link.springer.com/article/10.1007%2Fs10549-015-3654-2 doi:10.1007/s10549-015-3654-2 doi:10.1007/s10549-015-3654-2 |
| spellingShingle | Negm, Ola H. Muftah, Abir A. Aleskandarany, Mohammed A. Hamed, Mohamed R. Ahmad, Dena A.J. Nolan, Christopher C. Diez-Rodriguez, Maria Tighe, Patrick J. Ellis, Ian O. Rakha, Emad A. Green, Andrew R. Clinical utility of reverse phase protein array for molecular classification of breast cancer |
| title | Clinical utility of reverse phase protein array for molecular classification of breast cancer |
| title_full | Clinical utility of reverse phase protein array for molecular classification of breast cancer |
| title_fullStr | Clinical utility of reverse phase protein array for molecular classification of breast cancer |
| title_full_unstemmed | Clinical utility of reverse phase protein array for molecular classification of breast cancer |
| title_short | Clinical utility of reverse phase protein array for molecular classification of breast cancer |
| title_sort | clinical utility of reverse phase protein array for molecular classification of breast cancer |
| url | https://eprints.nottingham.ac.uk/44244/ https://eprints.nottingham.ac.uk/44244/ https://eprints.nottingham.ac.uk/44244/ |